bioRxivNeurosciencePreprint
Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson disease
Pierre GarciaiD, Wiebke M. WemheueriD, Oihane Uriarte HuarteiD, Kristopher J. SchmitiD, Annette MasuchiD, Simone BrioschiiD, Andreas WeihofeniD, Eric KoncinaiD, Djalil CoowariD, Tony HeurtauxiD, Enrico GlaabiD, Rudi BallingiD, Carole SousaiD, Alessandro MichelucciiD, Tony KaomaiD, Nathalie NicotiD, Tatjana Pfander, Walter Schulz‐SchaefferiD, Ahmad Allouche, Nicolas Fischer, Knut P. H. BiberiD, Michel Guy André MittelbronniD, Manuel ButtiniiD
Abstract
A key process of neurodegeneration in Parkinson disease (PD) is the transneuronal spreading of alpha-synuclein. Alpha-synuclein is a presynaptic protein that is implicated in the pathogenesis of PD and other synucleinopathies, where it forms, upon intracellular aggregation, pathological inclusions. Other hallmarks of PD include neurodegeneration and microgliosis in susceptible brain regions. Whether it is primarily transneuronal spreading of alpha-synuclein particles, inclusion formation, or other mechanisms, such as inflammation, that cause neurodegeneration in PD is unclear. We used spreading/aggregation of alpha-synuclein induced by intracerebral injection of alpha-synuclein preformed fibrils into the mouse brain to address this question. We performed quantitative histological analysis for alpha-synuclein inclusions, neurodegeneration, and microgliosis in different brain regions, and a gene expression profiling of the ventral midbrain, at two different timepoints after disease induction. We observed significant neurodegeneration and microgliosis in brain regions not only with, but also without alpha-synuclein inclusions. We also observed prominent microgliosis in injured brain regions that did not correlate with neurodegeneration nor with inclusion load. In longitudinal gene expression profiling experiments, we observed early and unique alterations linked to microglial mediated inflammation that preceded neurodegeneration, indicating an active role of microglia in inducing neurodegeneration. Our observations indicate that alpha-synuclein inclusion formation is not the major driver in the early phases of PD-like neurodegeneration, but that diffusible, oligomeric alpha-synuclein species, which induce unusual microglial reactivity, play a key role in this process. Our findings uncover new features of alpha-synuclein induced pathologies, in particular microgliosis, and point to the necessity of a broader view of the process of prion-like spreading of that protein.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Intranigral injection of Alpha-Synuclein pre-formed fibrils leads to BBB compromise and Bilateral Dopaminergic Neurodegeneration in A53T Alpha-Synuclein transgenic mice.
Soumitra Ghosh, Han Lin, … William J. Meilandt·Discover NeurosciencePeer-reviewed·Aug 27, 2026
- Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson's disease
James R. Evans, Melissa Grant‐Peters, … Sonia Gandhi·bioRxiv·Aug 25, 2025
- Parkinson's disease-derived α-Synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
Cansu Yildirim, Alexis Fenyi, … Stéphane Hunot·bioRxiv·Nov 30, 2023
- An In Vivo Model of Alpha-Synuclein Spread from Gut to Brain
Lisa M. Barnhill, Sataree Khuansuwan, … Jeff M. Bronstein·bioRxiv·Mar 13, 2025
- Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy.
Matthew D. Byrne, Peyman Petramfar, Richard Jay Smeyne·bioRxiv·Jul 29, 2024
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice
Akshaya Rajan, Anish Varghese, … Poonam Singh Thakur·ACS Chemical NeurosciencePeer-reviewed·Sep 12, 2025